BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 19 filers reported holding BIOPHARMX CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $17,000 | -39.3% | 58,027 | 0.0% | 0.01% | -37.5% |
| Q2 2017 | $28,000 | +100.0% | 58,027 | +107.0% | 0.01% | +100.0% |
| Q1 2017 | $14,000 | +40.0% | 28,027 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $10,000 | -37.5% | 28,027 | 0.0% | 0.00% | -40.0% |
| Q3 2016 | $16,000 | – | 28,027 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 16,128,515 | $3,561,000 | 0.46% |
| Virtu Financial LLC | 580,070 | $128,000 | 0.01% |
| FRG Family Wealth Advisors LLC | 30,000 | $7,000 | 0.00% |
| FRANKLIN RESOURCES INC | 9,749,615 | $2,153,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 671,686 | $148,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 16,779 | $4,000 | 0.00% |
| OPPENHEIMER & CO INC | 35,000 | $8,000 | 0.00% |
| CREDIT SUISSE AG/ | 50,003 | $11,000 | 0.00% |
| MORGAN STANLEY | 100 | $0 | 0.00% |
| Invesco Ltd. | 51,964 | $11,000 | 0.00% |